会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明申请
    • ROOT CANAL FILLER AND DENTAL TISSUE REGENERATION METHOD
    • ROOT CANAL FILLER和牙齿组织再生方法
    • US20110020310A1
    • 2011-01-27
    • US12922097
    • 2009-03-12
    • Misako NakashimaKoichiro Iohara
    • Misako NakashimaKoichiro Iohara
    • A61K35/12A61P1/02
    • A61L27/3834A61K6/0032A61L27/3633A61L27/3865A61L2400/06A61L2430/12
    • Provided is a novel and creative dental tissue regeneration method for regenerating dental tissue after pulpectomy or the enlargement and cleaning of an infected root canal. After pulpectomy or the enlargement and cleaning of an infected root canal, a root canal filler (200) having an extracellular matrix (210) containing the cells (220) enriched for dental pulp stem cells, is inserted into the apical side of the root canal of a target tooth (100). The cells including dental pulp stem cells include at least one of the following: dental pulp SP cells, CD31-negative and CD146-negative cells, CD24-positive cells, CD105-positive cells, and CD150-positive cells. For instance, dental pulp SP cells are CD31− and CD146− negative. Even if pulpitis due to deep caries occurs, appropriate dental pulp regeneration and recovery of dental pulp function are possible.
    • 提供了一种新颖创新的牙科组织再生方法,用于在切除术后进行牙齿组织再生或扩大和清洁受感染的根管。 在进行切割或扩大和清洁感染的根管之后,将含有富含牙髓干细胞的细胞(220)的细胞外基质(210)的根管填料(200)插入到根管的顶端 的目标牙齿(100)。 包括牙髓干细胞的细胞包括以下至少一种:牙髓SP细胞,CD31阴性和CD146阴性细胞,CD24阳性细胞,CD105阳性细胞和CD150阳性细胞。 例如,牙髓SP细胞是CD31-和CD146-阴性的。 即使发生由于深度龋齿引起的牙髓炎,也可以适当地进行牙髓再生和恢复牙髓功能。
    • 7. 发明授权
    • Root canal filler and dental tissue regeneration method
    • 根管填充和牙组织再生方法
    • US08920791B2
    • 2014-12-30
    • US12922097
    • 2009-03-12
    • Misako NakashimaKoichiro Iohara
    • Misako NakashimaKoichiro Iohara
    • A61K6/02A61K35/12A61L27/38A61K6/00A61L27/36
    • A61L27/3834A61K6/0032A61L27/3633A61L27/3865A61L2400/06A61L2430/12
    • Provided is a novel and creative dental tissue regeneration method for regenerating dental tissue after pulpectomy or the enlargement and cleaning of an infected root canal. After pulpectomy or the enlargement and cleaning of an infected root canal, a root canal filler (200) having an extracellular matrix (210) containing the cells (220) enriched for dental pulp stem cells, is inserted into the apical side of the root canal of a target tooth (100). The cells including dental pulp stem cells include at least one of the following: dental pulp SP cells, CD31-negative and CD146-negative cells, CD24-positive cells, CD105-positive cells, and CD150-positive cells. For instance, dental pulp SP cells are CD31− and CD146− negative. Even if pulpitis due to deep caries occurs, appropriate dental pulp regeneration and recovery of dental pulp function are possible.
    • 提供了一种新颖创新的牙科组织再生方法,用于在切除术后进行牙齿组织再生或扩大和清洁受感染的根管。 在进行切割或扩大和清洁感染的根管之后,将含有富含牙髓干细胞的细胞(220)的细胞外基质(210)的根管填料(200)插入到根管的顶端 的目标牙齿(100)。 包括牙髓干细胞的细胞包括以下至少一种:牙髓SP细胞,CD31阴性和CD146阴性细胞,CD24阳性细胞,CD105阳性细胞和CD150阳性细胞。 例如,牙髓SP细胞是CD31-和CD146-阴性的。 即使发生由于深度龋齿引起的牙髓炎,也可以适当地进行牙髓再生和恢复牙髓功能。
    • 9. 发明申请
    • MATERIAL FOR TREATMENT OF CEREBRAL INFARCTION AND BRAIN TISSUE REGENERATION METHOD
    • 治疗脑膜炎和脑组织再生方法的材料
    • US20110177041A1
    • 2011-07-21
    • US13059710
    • 2009-08-21
    • Misako NakashimaMasahiko Sugiyama
    • Misako NakashimaMasahiko Sugiyama
    • A61K35/12A61P25/00
    • A61K35/32A61L27/3834A61L27/3878
    • Disclosed is a therapeutic material for cerebral infarction, which can recover a vascular disorder in an area affected by cerebral infarction to improve the brain function. The therapeutic material for cerebral infarction includes a dental pulp stem cell comprising at least one member selected from a CD105-positive cell, an SP cell, a CD24-positive cell, a CD133-positive cell, a CD271-positive cell and a CD150-positive cell. The therapeutic material may additionally include a protein secreted from a dental pulp cell. A transplanted dental pulp stem cell cannot be differentiated directly into a neural progenitor cell or a neurocyte, but is involved indirectly in the promotion of differentiation to eliminate an area affected by cerebral infarction, thereby recovering the affected area into a normal area.
    • 本发明公开了脑梗死治疗材料,其可以恢复受脑梗死影响的区域的血管疾病,以改善脑功能。 脑梗死治疗材料包括:牙髓干细胞,其包含选自CD105阳性细胞,SP细胞,CD24阳性细胞,CD133阳性细胞,CD271阳性细胞和CD150细胞中的至少一种, 阳性细胞。 治疗材料还可以包括从牙髓细胞分泌的蛋白质。 移植的牙髓干细胞不能直接分化成神经祖细胞或神经细胞,而是间接地涉及促进分化以消除受脑梗死影响的区域,从而将受影响的区域恢复到正常区域。
    • 10. 发明授权
    • Dental ultrasonic drug delivery system and dental ultrasonic drug delivery method
    • 牙科超声药物输送系统和牙科超声药物递送方法
    • US09452036B2
    • 2016-09-27
    • US13516678
    • 2010-12-16
    • Misako NakashimaKatsuro Tachibana
    • Misako NakashimaKatsuro Tachibana
    • A61C1/07A61C17/02A61C17/20A61C5/02
    • A61C17/0202A61C5/40A61C17/20
    • A dental ultrasonic drug delivery system capable of accurately cleaning the inside of root canals and killing bacteria in dentin tubules is provided. The dental ultrasonic drug delivery system delivers a drug to a target using an ultrasonic delivery device 800 . The drug is delivered in a mixed state with nanobubbles. A dental therapeutic probe for applying ultrasound is attached to the ultrasonic delivery device 800 . The dental therapeutic probe is selected from: (1) a root canal insertion probe 100 which is configured to be inserted into a root canal and causes ultrasound to propagate in the root canal; (2) a dental caries therapeutic probe which causes ultrasound to propagate in a dental caries portion; (3) a periodontal disease therapeutic probe which applies ultrasound to a periodontal disease portion; and (4) a hyperesthesia therapeutic probe which applies ultrasound to hyperesthesia portion.
    • 提供了能够精确地清洁牙根内部的牙科超声药物递送系统和杀死牙本质细管的细菌。 牙科超声药物递送系统使用超声波输送装置800向药物递送药物。 药物以纳米气泡的混合状态递送。 用于施加超声波的牙科治疗探针附接到超声输送装置800。 牙科治疗探针选自:(1)根管插入探针100,其构造成插入根管中并使超声在根管中传播; (2)使龋齿治疗探针引起超声波在龋齿部分中传播; (3)牙周病治疗探针,将超声波应用于牙周病部位; 和(4)将超声波应用于感觉过敏部位的感叹治疗探针。